Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chattem Inc.

Division of Sanofi
www.chattem.com

Latest From Chattem Inc.

ACT Dry Mouth Claims Get Parched In Industry Self-Regulation Review

Sanofi and GSK appeal Council of Better Business Bureaus investigative arm's recommendations from review of  ACT Dry Mouth ad claims. GSK disagrees that Sanofi's could continue using a claim of "moisturizes dry mouth" and Sanofi disagrees that it did not substantiate claims that established ACT Dry Mouth, marketed with cavity prevention claims, as providing benefits similar to GSK's Biodene, which has pre-market approval for an indication of lubricating and coating the interior of the mouth and gums with moisture.

United States France

ACT Dry Mouth Claims Get Parched In Industry Self-Regulation Review

Biodene maker GSK challenged Sanofi's ACT Dry Mouth advertising and both companies find disappointments in the Better Business Bureaus' advertising division's review.

Advertising, Marketing & Sales United States

ACT Dry Mouth Claims Get Parched In Industry Self-Regulation Review

Biodene maker GSK challenged Sanofi's ACT Dry Mouth advertising and both companies find disappointments in the Better Business Bureaus' advertising division's review.

Advertising, Marketing & Sales United States

Sanofi's Consumer Health Q2 Results Ride Emerging Markets Boost

French pharma's worldwide OTC drug and other consumer health product sales grow 4.1% to $1.3bn led by more than 10% growth in its emerging markets, but US sales fell nearly 6% partly due to market-share incursion by private label OTCs.

Sales & Earnings Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Contact Info
  • Chattem Inc.
    Phone: (615) 821-4571
    1715 West 38th St.
    P.O. Box 2219 Chattanooga, TN 37409
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register